Pro ad report: All the data on journal spending in 1H 2016

Share this content:

Professional advertising spending behind brands like Gilead Sciences' hepatitis-C pill Harvoni and Allergan's IBS drug Viberzi buoyed med-surg outlays for the first six months of 2016. But cancer drugs once again were the hottest category. Check out the latest data on professional ad spending here or read a deep drive into Merck's journal spending on Keytruda, its immuno-oncology therapy, in the first half of 2016. 



Source: Kantar Media

Share this content: